Literature DB >> 17493431

Thalidomide-induced fulminant hepatic failure.

Mehdi Hamadani, Don M Benson, Edward A Copelan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17493431     DOI： 10.4065/82.5.638

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

1.  Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?

Authors:  Javier Molina-Infante; Belen Perez-Gallardo
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

Review 2.  The use of novel agents in multiple myeloma patients with hepatic impairment.

Authors:  Lindsay C Stansfield; Wilson I Gonsalves; Francis K Buadi
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

Review 3.  Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.

Authors:  My-Linh Tran-Minh; Paula Sousa; Marianne Maillet; Matthieu Allez; Jean-Marc Gornet
Journal:  World J Hepatol       Date:  2017-05-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.